Apollo Endosurgery 

$10
2
+$0.07+0.76% Monday 20:00

统计

当日最高
-
当日最低
-
52周高点
-
52周低点
-
成交量
-
平均成交量
-
市值
416.34M
市盈率
0
股息率
-
股息
-

财报

1May预期
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Q1 2023
-0.28
-0.25
-0.22
-0.19
预期EPS
-0.2167
实际EPS
不适用

财务

-51.84%利润率
未盈利
2017
2018
2019
2020
2021
2022
76.86M营收
-39.84M净利润

其他人也在关注

此列表基于在 Stock Events 上关注 APEN 的用户自选生成。这不是投资建议。

竞争对手

此列表为基于近期市场事件的分析。并非投资建议。

关于

Health Technology
Medical Specialties
Manufacturing
Biological Product (except Diagnostic) Manufacturing
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, as well as delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. Additionally, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Australia, Costa Rica, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.
Show more...
首席执行官
Gary Atkinson
员工
202
国家
US
ISIN
US03767D1081
WKN
000A2DJ26

上市

0 Comments

分享你的想法

FAQ

Apollo Endosurgery 今天的股价是多少?
APEN 当前价格为 $10 USD,过去 24 小时上涨了 +0.76%。在图表上更密切关注 Apollo Endosurgery 股价表现。
Apollo Endosurgery 的股票代码是什么?
根据交易所不同,股票代码可能会有所不同。例如,在 交易所,Apollo Endosurgery 的股票以代码 APEN 进行交易。
Apollo Endosurgery 的市值是多少?
今天 Apollo Endosurgery 的市值为 416.34M
Apollo Endosurgery 去年的营收是多少?
Apollo Endosurgery 去年的营收为 76.86MUSD。
Apollo Endosurgery 去年的净利润是多少?
APEN 去年的净收益为 -39.84MUSD。
Apollo Endosurgery 有多少名员工?
截至四月 01, 2026,公司共有202名员工。
Apollo Endosurgery 属于哪个行业?
Apollo Endosurgery从事于Manufacturing行业。
Apollo Endosurgery 何时完成拆股?
Apollo Endosurgery 上次拆股发生在 十二月 30, 2016,比例为 1:5.5。
Apollo Endosurgery 的总部在哪里?
Apollo Endosurgery 的总部位于 US 的 San Diego。